Patent · US Active

Agents, compositions, and methods for treating pruritus and related skin conditions

US9241991B2 · kind B2 · utility

28Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2011
Grant dateJan 26, 2016
Priority date
Expiry dateMay 3, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates generally to a therapeutic use of TLR3 and TLR7 inhibitors to treat or reduce pruritus in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.